Last reviewed · How we verify
NCT03686085
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
Phase 3 trial testing Dinoprostone 3 mg in Intrauterine Device in 200 participants. Completed in 10 March 2019.
1 March 2019
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 30 September 2018 |
| Primary completion | 1 March 2019 |
| Estimated completion | 10 March 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Dinoprostone 3 mg — full drug profile →
- placebo vaginal tablet — full drug profile →
Conditions studied
- Intrauterine Device — all drugs for Intrauterine Device →
Sponsor
Cairo University
Who can join
18 and older, female only, with Intrauterine Device. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate whether vaginal dinoprostone administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in nulliparous women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03686085
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dinoprostone 3 mg
Trials testing the same drug.
- NCT05342467 — Gemeprost Versus Dinoprostone in First Trimester Miscarriages · Phase 2 · completed
- NCT04080323 — Single-dose Vaginal Dinoprostone and Hysterectomy · Phase 3 · completed
- NCT04080375 — Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy · Phase 3 · unknown
- NCT04080349 — Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only · Phase 4 · unknown
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03686085 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 30 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03686085.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing